Loading...
Header Logo
Keywords
Last Name
Institution

HOONMO KOO

TitleClinical Associate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
DivisionMedicine-Infectious Disease
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Research 
    Collapse research activities and funding
    K23DK084513     (KOO, HOONMO LEE)Jul 1, 2009 - Jun 30, 2014
    NIH/NIDDK
    Host Genetic Susceptibility and Immune Responses to Norovirus Infections
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Musher DM, Koo H. Non-toxigenic Clostridium difficile to prevent recurrent C. difficile infection. Evid Based Med. 2016 Apr; 21(2):67. PMID: 26763618.
      View in: PubMed
    2. Garey KW, Aitken SL, Dima-Ala A, Beyda ND, Kuper K, Xie Y, Koo HL. Echinocandin use in hospitalized patients: a multi-institutional study. Am J Med Sci. 2015 Apr; 349(4):316-20. PMID: 25607510.
      View in: PubMed
    3. Aitken SL, Hemmige VS, Koo HL, Vuong NN, Lasco TM, Garey KW. Real-world performance of a microarray-based rapid diagnostic for Gram-positive bloodstream infections and potential utility for antimicrobial stewardship. Diagn Microbiol Infect Dis. 2015 Jan; 81(1):4-8. PMID: 25445120.
      View in: PubMed
    4. Crews JD, Koo HL, Jiang ZD, Starke JR, DuPont HL. A hospital-based study of the clinical characteristics of Clostridium difficile infection in children. Pediatr Infect Dis J. 2014 Sep; 33(9):924-8. PMID: 25361022.
      View in: PubMed
    5. Koo HL, Van JN, Zhao M, Ye X, Revell PA, Jiang ZD, Grimes CZ, Koo DC, Lasco T, Kozinetz CA, Garey KW, DuPont HL. Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-associated disease rates. Infect Control Hosp Epidemiol. 2014 Jun; 35(6):667-73. PMID: 24799643.
      View in: PubMed
    6. Aitken SL, Beyda ND, Shah DN, Palmer HR, Lasco TM, Koo H, Garey KW. Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics. Ann Pharmacother. 2014 Jun; 48(6):683-90. PMID: 24687545.
      View in: PubMed
    7. Darkoh C, Turnwald BP, Koo HL, Garey KW, Jiang ZD, Aitken SL, DuPont HL. Colonic immunopathogenesis of Clostridium difficile infections. Clin Vaccine Immunol. 2014 Apr; 21(4):509-17. PMID: 24477852.
      View in: PubMed
    8. Dinardo AR, Lewis DS, Koo HL, Goodman JC, Chiao E, Andrade R. Paradoxical immune reconstitution inflammatory syndrome due to toxoplasmic encephalitis: two cases and review of initiation of antiretroviral timing in toxoplasmic encephalitis IRIS. F1000Res. 2013; 2:133. PMID: 24358883.
      View in: PubMed
    9. Koo HL, Neill FH, Estes MK, Munoz FM, Cameron A, DuPont HL, Atmar RL. Noroviruses: The Most Common Pediatric Viral Enteric Pathogen at a Large University Hospital After Introduction of Rotavirus Vaccination. J Pediatric Infect Dis Soc. 2013 Mar; 2(1):57-60. PMID: 23687584.
      View in: PubMed
    10. Khalaf N, Crews JD, DuPont HL, Koo HL. Clostridium difficile: an emerging pathogen in children. Discov Med. 2012 Aug; 14(75):105-13. PMID: 22935207.
      View in: PubMed
    11. Koo HL, Sabounchi S, Huang DB, DuPont HL. Rifaximin therapy of irritable bowel syndrome. Clin Med Insights Gastroenterol. 2012; 5:31-41. PMID: 24833932.
      View in: PubMed
    12. Siddiq DM, Koo HL, Adachi JA, Viola GM. Norovirus gastroenteritis successfully treated with nitazoxanide. J Infect. 2011 Nov; 63(5):394-7. PMID: 21839773.
      View in: PubMed
    13. Koo HL, Ajami N, Atmar RL, DuPont HL. Noroviruses: The leading cause of gastroenteritis worldwide. Discov Med. 2010 Jul; 10(50):61-70. PMID: 20670600.
      View in: PubMed
    14. Koo HL, Garey KW, Dupont HL. Future novel therapeutic agents for Clostridium difficile infection. Expert Opin Investig Drugs. 2010 Jul; 19(7):825-36. PMID: 20521993.
      View in: PubMed
    15. Shah D, Dang MD, Hasbun R, Koo HL, Jiang ZD, DuPont HL, Garey KW. Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance. Expert Rev Anti Infect Ther. 2010 May; 8(5):555-64. PMID: 20455684.
      View in: PubMed
    16. Koo HL, Ajami NJ, Jiang ZD, Neill FH, Atmar RL, Ericsson CD, Okhuysen PC, Taylor DN, Bourgeois AL, Steffen R, DuPont HL. Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico. J Clin Microbiol. 2010 May; 48(5):1673-6. PMID: 20305012.
      View in: PubMed
    17. Koo HL, DuPont HL. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol. 2010 Jan; 26(1):17-25. PMID: 19881343.
      View in: PubMed
    18. Koo HL, Dupont HL, Huang DB. The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea. Ther Clin Risk Manag. 2009; 5:841-8. PMID: 19898648.
      View in: PubMed
    19. Koo HL, DuPont HL. Noroviruses as a potential cause of protracted and lethal disease in immunocompromised patients. Clin Infect Dis. 2009 Oct 01; 49(7):1069-71. PMID: 19705972.
      View in: PubMed
    20. Koo HL, Ajami NJ, Jiang ZD, Dupont HL, Atmar RL, Lewis D, Byers P, Abraham P, Quijano RA, Musher DM, Young EJ. A nosocomial outbreak of norovirus infection masquerading as clostridium difficile infection. Clin Infect Dis. 2009 Apr 01; 48(7):e75-7. PMID: 19245344.
      View in: PubMed
    21. Vigil KJ, Jiang ZD, Chen JJ, Palumbo KL, Galbadage T, Brown EL, Yiang J, Koo H, DuPont MW, Ericsson C, Adachi JA, DuPont HL. Coliform and Escherichia coli contamination of desserts served in public restaurants from Guadalajara, Mexico, and Houston, Texas. Am J Trop Med Hyg. 2009 Apr; 80(4):606-8. PMID: 19346385.
      View in: PubMed
    22. Koo HL, Koo DC, Musher DM, DuPont HL. Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis. Clin Infect Dis. 2009 Mar 01; 48(5):598-605. PMID: 19191646.
      View in: PubMed
    23. Koo HL, Jiang ZD, Brown E, Garcia C, Qi H, Dupont HL. Coliform contamination of vegetables obtained from popular restaurants in Guadalajara, Mexico, and Houston, Texas. Clin Infect Dis. 2008 Jul 15; 47(2):218-21. PMID: 18540820.
      View in: PubMed
    24. Koo HL, Hamill RJ, Andrade RA. Drug-drug interaction between itraconazole and efavirenz in a patient with AIDS and disseminated histoplasmosis. Clin Infect Dis. 2007 Sep 15; 45(6):e77-9. PMID: 17712747.
      View in: PubMed
    25. Koo HL, DuPont HL. Current and future developments in travelers' diarrhea therapy. Expert Rev Anti Infect Ther. 2006 Jun; 4(3):417-27. PMID: 16771619.
      View in: PubMed
    26. Huang DB, Koo H, DuPont HL. Enteroaggregative Escherichia coli: An Emerging Pathogen. Curr Infect Dis Rep. 2004 Apr; 6(2):83-86. PMID: 15023269.
      View in: PubMed
    27. Huang DB, Koo H, Dougherty D, Hassan Y. Psychopathology among persons responding to participation as normal controls in behavioral research studies. Compr Psychiatry. 2003 Mar-Apr; 44(2):83-7. PMID: 12658616.
      View in: PubMed
    KOO's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description